Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection

被引：65
|
作者：
Barbaro, G [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Rome, Italy
来源：
CURRENT HIV RESEARCH | 2006年 / 4卷 / 01期
关键词：
human immunodeficiency virus; highly active antiretroviral therapy; nucleoside reverse transcriptase inhibitors; protease inhibitors; metabolic syndome; cardiovascular disease;
D O I：
10.2174/157016206775197664
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Highly active antiretroviral therapy (HAART) regimens, especially those including protease inhibitors have been shown to cause, in a high proportion of HIV-infected patients, a metabolic syndrome (lipodystrophy/lipoatrophy, dyslipidemia, type 2 diabetes mellitus, insulin resistance) that may be associated with an increased risk of cardiovascular disease. A careful stratification of the cardiovascular risk of HIV-infected patients under HAART is needed according to the most recent clinical guidelines.
引用
收藏
页码：79 / 85
页数：7
相关论文
共 50 条
  • [31] Response to highly active antiretroviral therapy according to duration of HIV infection
    Pezzotti, P
    Pappagallo, M
    Phillips, PN
    Boros, S
    Valdarchi, C
    Sinicco, A
    Zaccarelli, M
    Rezza, G
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (05) : 473 - 479
  • [32] HIV infection and cancer in the era of highly active antiretroviral therapy (Review)
    Barbaro, Giuseppe
    Barbarini, Giorgio
    [J]. ONCOLOGY REPORTS, 2007, 17 (05) : 1121 - 1126
  • [33] Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy
    Wolff, AJ
    O'Donnell, AE
    [J]. CHEST, 2001, 120 (06) : 1888 - 1893
  • [34] Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk
    Barbaro, Giuseppe
    Barbarini, Giorgio
    [J]. CHEMOTHERAPY, 2006, 52 (04) : 161 - 165
  • [35] Cardiovascular disease in HIV-infected patients on highly active antiretroviral therapy
    Jericó, C
    Knobel, H
    Carmona, A
    Sorli, ML
    López-Colomés, JL
    Pedro-Botet, J
    [J]. MEDICINA CLINICA, 2004, 122 (08): : 298 - 300
  • [36] Disseminated rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy
    Francesca Ferretti
    Antonio Boschini
    Cristiana Iabichino
    Simonetta Gerevini
    Paola De Nardi
    Monica Guffanti
    Giuseppe Balconi
    Adriano Lazzarin
    Paola Cinque
    [J]. BMC Infectious Diseases, 11
  • [37] Disseminated Rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy
    Ferretti, Francesca
    Boschini, Antonio
    Iabichino, Cristiana
    Gerevini, Simonetta
    De Nardi, Paola
    Guffanti, Monica
    Balconi, Giuseppe
    Lazzarin, Adriano
    Cinque, Paola
    [J]. BMC INFECTIOUS DISEASES, 2011, 11
  • [38] Hiv Infection, Antiretroviral Therapy and Cardiovascular Risk
    Donati, Katleen de Gaetano
    Cauda, Roberto
    Iacoviello, Licia
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2010, 2 (03):
  • [39] HIV infection, antiretroviral therapy and cardiovascular risk
    Barbaro, G
    [J]. JOURNAL OF CARDIOVASCULAR RISK, 2002, 9 (05): : 295 - 300
  • [40] Highly active antiretroviral therapy and HIV transmission
    Montaner, Julio
    [J]. LANCET, 2006, 368 (9548): : 1647 - 1647
12345